# Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer

> **NCT00820248** · PHASE3 · COMPLETED · sponsor: **NCIC Clinical Trials Group** · enrollment: 320 (actual)

## Conditions studied

- Head and Neck Cancer

## Interventions

- **BIOLOGICAL:** panitumumab
- **DRUG:** cisplatin
- **RADIATION:** 3-dimensional conformal radiation therapy
- **RADIATION:** accelerated radiation therapy
- **RADIATION:** intensity-modulated radiation therapy

## Key facts

- **NCT ID:** NCT00820248
- **Lead sponsor:** NCIC Clinical Trials Group
- **Sponsor class:** NETWORK
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-12-30
- **Primary completion:** 2015-05-16
- **Final completion:** 2017-02-17
- **Target enrollment:** 320 (ACTUAL)
- **Last updated:** 2023-08-22


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00820248

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00820248, "Radiation + Cisplatin or Panitumumab in Locally Advanced Stage III or Stage IV Head and Neck Cancer". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00820248. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*